DK166431B1 - Intravenoest administrerbar oploesning til behandling af metabolisk acidosis - Google Patents

Intravenoest administrerbar oploesning til behandling af metabolisk acidosis Download PDF

Info

Publication number
DK166431B1
DK166431B1 DK026785A DK26785A DK166431B1 DK 166431 B1 DK166431 B1 DK 166431B1 DK 026785 A DK026785 A DK 026785A DK 26785 A DK26785 A DK 26785A DK 166431 B1 DK166431 B1 DK 166431B1
Authority
DK
Denmark
Prior art keywords
solution
sodium
treatment
blood
patient
Prior art date
Application number
DK026785A
Other languages
Danish (da)
English (en)
Other versions
DK26785D0 (da
DK26785A (da
Inventor
Giles F Filley
Neal B Kindig
Original Assignee
Webb Waring Lung Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Webb Waring Lung Inst filed Critical Webb Waring Lung Inst
Publication of DK26785D0 publication Critical patent/DK26785D0/da
Publication of DK26785A publication Critical patent/DK26785A/da
Application granted granted Critical
Publication of DK166431B1 publication Critical patent/DK166431B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK026785A 1984-01-20 1985-01-18 Intravenoest administrerbar oploesning til behandling af metabolisk acidosis DK166431B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57223584 1984-01-20
US06/572,235 US4548817A (en) 1984-01-20 1984-01-20 Composition and method for treating mammalian acidosis

Publications (3)

Publication Number Publication Date
DK26785D0 DK26785D0 (da) 1985-01-18
DK26785A DK26785A (da) 1985-07-21
DK166431B1 true DK166431B1 (da) 1993-05-24

Family

ID=24286929

Family Applications (1)

Application Number Title Priority Date Filing Date
DK026785A DK166431B1 (da) 1984-01-20 1985-01-18 Intravenoest administrerbar oploesning til behandling af metabolisk acidosis

Country Status (14)

Country Link
US (1) US4548817A (de)
EP (1) EP0150115B1 (de)
JP (1) JPS60226813A (de)
AT (1) ATE35221T1 (de)
AU (1) AU564865B2 (de)
CA (1) CA1254518A (de)
DE (1) DE3563417D1 (de)
DK (1) DK166431B1 (de)
ES (1) ES8609159A1 (de)
FI (1) FI850251L (de)
HK (1) HK52891A (de)
IE (1) IE57970B1 (de)
NZ (1) NZ210902A (de)
SG (1) SG45591G (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256660A (en) * 1987-12-14 1993-10-26 Henry Swan Ii Trust Synthetic buffer composition for clinical use
US5112622A (en) * 1990-01-19 1992-05-12 Kopp Klaus F Intravenous solutions for influencing renal function and for maintenance therapy
DE4125819A1 (de) * 1991-08-03 1993-02-04 Rolf Prof Dr Med Zander Waessrige loesung und deren verwendung
US5278149A (en) * 1992-01-17 1994-01-11 New England Deaconess Hospital Corporation Method of preparing total parenteral nutrition solutions
AU735435B2 (en) * 1997-03-17 2001-07-05 Lachlan Family Pty Limited, The An aqueous metal bicarbonate solution and method of use
US6048553A (en) 1997-03-17 2000-04-11 Macquarie Veterinary Supplies Pty Ltd Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases
US8592421B2 (en) * 2003-08-04 2013-11-26 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
SE0400523D0 (sv) * 2004-03-01 2004-03-01 Gambro Lundia Ab A medical solution, a method for producing said medical solution and use thereof
SE0402507D0 (sv) 2004-10-14 2004-10-14 Gambro Lundia Ab Medicinsk lösning, förfarande för framställning och användning därav
WO2014028945A1 (en) * 2012-08-17 2014-02-20 The Regents Of The University Of California Systems, methods and compositions for improved treatment of acidosis
US11925703B1 (en) 2022-07-29 2024-03-12 Xellia Pharmaceuticals Aps Liquid composition comprising glucose

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3253988A (en) * 1962-11-20 1966-05-31 Robert I Pearlman Antacid composition and method of using same
US3621094A (en) * 1968-04-05 1971-11-16 Smith Kline French Lab Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level

Also Published As

Publication number Publication date
CA1254518A (en) 1989-05-23
DK26785D0 (da) 1985-01-18
EP0150115A2 (de) 1985-07-31
NZ210902A (en) 1987-10-30
IE850111L (en) 1985-07-20
ES8609159A1 (es) 1986-07-16
US4548817A (en) 1985-10-22
JPS60226813A (ja) 1985-11-12
FI850251A0 (fi) 1985-01-18
AU3779885A (en) 1985-08-01
FI850251L (fi) 1985-07-21
EP0150115A3 (en) 1985-08-07
HK52891A (en) 1991-07-19
JPH0212450B2 (de) 1990-03-20
DK26785A (da) 1985-07-21
DE3563417D1 (en) 1988-07-28
SG45591G (en) 1991-07-26
AU564865B2 (en) 1987-08-27
ES539705A0 (es) 1986-07-16
EP0150115B1 (de) 1988-06-22
ATE35221T1 (de) 1988-07-15
IE57970B1 (en) 1993-06-02

Similar Documents

Publication Publication Date Title
Moore et al. Oxygen: the antidote for systemic toxic reactions from local anesthetic drugs
Celleno et al. Which induction drug for cesarean section? A comparison of thiopental sodium, propofol, and midazolam
DK166431B1 (da) Intravenoest administrerbar oploesning til behandling af metabolisk acidosis
Blalock Mechanism and Treatment of Experimental Shock: I. Shock Following Hemorrhage
Doyle et al. IV ANAESTHESIA WITH PROPOFOL USING A TRAGET-CONTROLLED INFUSION SYSTEM: COMPARISON WITH INHALATION ANAESTHESIA FOR GENERAL SURGICAL PROCEDURES IN CHILDREN
EP0696197B1 (de) Analgetische und anästhetische zusammensetzung
Paterson et al. Intradural morphine and diamorphine: Dose response studies
Cunningham Oxygen Therapy by Means of Compressed Air.
TWI737776B (zh) 用於改善及／或安定化出血性休克發生後之循環動態之醫藥組成物
Magno et al. Anesthesia for Cesarean Section II: Effects of the Induction‐Delivery Interval on the Respiratory Adaptation of the Newborn in Elective Cesarean Section
Marciniak et al. The impact of colloid infusion prior to spinal anaesthesia for caesarean section on the condition of a newborn—a comparison of balanced and unbalanced hydroxyethyl starch 130/0.4
World Health Organization WHO model prescribing information: drugs used in anaesthesia
Vermeulen-Cranch Anaesthesia in a high pressure chamber
Restall et al. Anaesthesia in the field. Spontaneous ventilation–a new technique
Marciniak et al. The impact of colloid infusion prior to spinal anaesthesia for caesarean section on the condition of a newborn—a comparison of balanced and unbalanced hydroxyethyl starch 130/0.4
RU2148980C1 (ru) Способ лечения респираторного дистресс-синдрома
Khaydarov et al. ANTI-SHOCK THERAPY FOR HEAVY AVIATION
Evans et al. Further Observations on Oxygen Therapy in the Treatment of Pneumonia.
Featherstone Notes on the physiology and pharmacology of anaesthesia
Hampton et al. Anesthesia for Surgical Correction of Cardiorespiratory Anomalies.
Epidural ANESTHESIA AND MATERNAL COMORBIDITIES
Evans The Preoperative and Postoperative Use of Oxygenxs
Trusler et al. The Relationship of Carbon Dioxid in the Blood to Asphyxia and the Activity of the Respiratory Center: General Considerations and Observations on the New-Born Infant
MASTER Heart Failure: Its Treatment—With Special Reference to Chronic Lung Disease
MAzEL et al. Prevention of Cardiac Arrest During Surgery

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed